Fostamatinib 100 mg bid and Paclitaxel
J1708
Phase 1 small_molecule completed
Quick answer
Fostamatinib 100 mg bid and Paclitaxel for Ovarian Cancer is a Phase 1 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Ovarian Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed